Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 5 Insider Annual Insider Trading Report
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $33.94 ($46,668)
  7. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $34.52 ($172,620)
  8. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $32.46 ($44,633)
  9. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $35.06 ($175,304)
  10. 4 Open-market sale Director sold 15,173 shares at $37.39 ($567,385)
  11. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $35.10 ($48,263)
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $37.19 ($185,956)
  14. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $39.95 ($54,931)
  15. 4 Other disposition Director disposed of 1,750,000 shares (other)
  16. 4 Other disposition 10% owner disposed of 1,750,000 shares (other)
  17. 4 Open-market sale 10% owner sold 400,022 shares at $52.73 ($21,093,160)
  18. 8-K Event Material agreement · Agreement ended · New debt or obligation
  19. 4 Open-market sale Director sold 15,174 shares at an average $54.53 ($827,485)
  20. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $50.72 ($253,608)

Page 24 of 41 · 806 filings